GlobeNewswire Inc.··NaInventiva to Showcase Lanifibranor Data at EASL Congress 2026
Inventiva will present two abstracts on lanifibranor's MASH treatment effectiveness at EASL Congress 2026 in Barcelona, highlighting cardiometabolic and histological improvements.
IVAPhase 3 clinical trialMASH treatment